No abstract available
Publication types
-
Multicenter Study
-
Observational Study
MeSH terms
-
Adalimumab / administration & dosage*
-
Adalimumab / adverse effects
-
Adult
-
Aged
-
Anti-Inflammatory Agents / administration & dosage*
-
Anti-Inflammatory Agents / adverse effects
-
Dermatologic Agents / administration & dosage*
-
Dermatologic Agents / adverse effects
-
Etanercept / administration & dosage*
-
Etanercept / adverse effects
-
Female
-
Humans
-
Italy
-
Male
-
Middle Aged
-
Psoriasis / diagnosis
-
Psoriasis / drug therapy*
-
Psoriasis / immunology
-
Recurrence
-
Remission Induction
-
Retrospective Studies
-
Risk Factors
-
Time Factors
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors
-
Tumor Necrosis Factor-alpha / immunology
Substances
-
Anti-Inflammatory Agents
-
Dermatologic Agents
-
Tumor Necrosis Factor-alpha
-
Adalimumab
-
Etanercept